Literature DB >> 15185867

Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes.

Marc J Zuckerman1, Ian S Menzies, Hoi Ho, Gavin G Gregory, Nancy A Casner, Roger S Crane, Jesus A Hernandez.   

Abstract

Gastrointestinal dysfunction in patients with cirrhosis may contribute to complications such as malnutrition and spontaneous bacterial peritonitis. To determine whether cirrhotic patients with ascites have altered intestinal function, we compared intestinal permeability and absorption in patients with liver disease and normal subjects. Intestinal permeability and absorption were investigated in 66 cirrhotic patients (48 with ascites, 18 without ascites) and 74 healthy control subjects. Timed recovery of 3-O-methyl-D-glucose, D-xylose, L-rhamnose, and lactulose in urine following oral administration was measured in order to assess active and passive carrier-mediated, and nonmediated, absorptive capacity, as well as intestinal large-pore/small-pore (lactulose/rhamnose) permeability. Test sugars were measured by quantitative thin-layer chromatography and results are expressed as a percentage of test dose recovered in a 5-h urine collection. Sugar excretion ratios relating to small intestinal permeability (lactulose/rhamnose) and absorption (rhamnose/3-O-methyl-D-glucose) were calculated to avoid the effects of nonmucosal factors such as renal clearance, portal hypertension, and ascites on the recovery of sugar probes in urine. Compared with normal subjects, the mean lactulose/rhamnose permeability ratio in cirrhotic patients with ascites was significantly higher (0.058 vs. 0.037, P < 0.001) but not in cirrhotic patients without ascites (0.041 vs. 0.037). Cirrhotic patients with ascites had significantly lower mean recoveries of 3-O-methyl-D-glucose (23.0 vs. 49.1%; P < 0.001), D-xylose (18.8 vs. 34.5%; P < 0.001), L-rhamnose (4.0 vs. 9.1%; P < 0.001), and lactulose (0.202 vs. 0.337%; P < 0.001) than normal subjects. However, the mean rhamnose/3-O-methyl-D-glucose ratio was the same in cirrhotic patients with ascites as normal subjects (0.189 vs. 0.189), indicating that the reduction in probe recovery was due to nonmucosal factors. Compared with normal subjects, cirrhotic patients with ascites have abnormal intestinal permeability, measured by urinary lactulose/rhamnose excretion, and normal small intestinal absorption, assessed by the urinary rhamnose/3-O-methyl-D-glucose ratio. Low urine recovery of sugar probes found in cirrhotic patients appears to be the result of nonintestinal factors affecting clearance rather than reduced intestinal absorption.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185867     DOI: 10.1023/b:ddas.0000026307.56909.21

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

Review 1.  D-xylose testing.

Authors:  R M Craig; E D Ehrenpreis
Journal:  J Clin Gastroenterol       Date:  1999-09       Impact factor: 3.062

2.  Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage.

Authors:  A Keshavarzian; E W Holmes; M Patel; F Iber; J Z Fields; S Pethkar
Journal:  Am J Gastroenterol       Date:  1999-01       Impact factor: 10.864

3.  Quantitative estimation of sugars in blood and urine by paper chromatography using direct densitometry.

Authors:  I S Menzies
Journal:  J Chromatogr       Date:  1973-06-27

4.  Distribution of d-xylose in sequestered fluid resulting in false-positive tests for malabsorption.

Authors:  G A Marin; M L Clark; J R Senior
Journal:  Ann Intern Med       Date:  1968-12       Impact factor: 25.391

Review 5.  Intestinal permeability: an overview.

Authors:  I Bjarnason; A MacPherson; D Hollander
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

6.  Abnormalities in proximal small bowel motility in patients with cirrhosis.

Authors:  J Chesta; C Defilippi; C Defilippi
Journal:  Hepatology       Date:  1993-05       Impact factor: 17.425

7.  Intestinal permeability in liver cirrhosis: relationship with severe septic complications.

Authors:  B Campillo; P Pernet; P N Bories; J P Richardet; M Devanlay; C Aussel
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-07       Impact factor: 2.566

8.  Geography of intestinal permeability and absorption.

Authors:  I S Menzies; M J Zuckerman; W S Nukajam; S G Somasundaram; B Murphy; A P Jenkins; R S Crane; G G Gregory
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

9.  Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis.

Authors:  J M Llovet; R Bartolí; R Planas; E Cabré; M Jimenez; A Urban; I Ojanguren; J Arnal; M A Gassull
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

10.  Abnormalities of gastric emptying in portal hypertension.

Authors:  K K Balan; S Grime; R Sutton; M Critchley; S A Jenkins
Journal:  Am J Gastroenterol       Date:  1996-03       Impact factor: 10.864

View more
  21 in total

Review 1.  Gut flora and bacterial translocation in chronic liver disease.

Authors:  John Almeida; Sumedha Galhenage; Jennifer Yu; Jelica Kurtovic; Stephen M Riordan
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 2.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

3.  Analysis of metabolism of 6FDG: a PET glucose transport tracer.

Authors:  Raymond F Muzic; Visvanathan Chandramouli; Hsuan-Ming Huang; Chunying Wu; Yanming Wang; Faramarz Ismail-Beigi
Journal:  Nucl Med Biol       Date:  2011-03-03       Impact factor: 2.408

4.  Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis.

Authors:  Carmen C Franz; Sabin Egger; Christa Born; Alexandra E Rätz Bravo; Stephan Krähenbühl
Journal:  Eur J Clin Pharmacol       Date:  2011-08-13       Impact factor: 2.953

Review 5.  Gastrointestinal dysfunction in liver cirrhosis.

Authors:  Evangelos Kalaitzakis
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

6.  Uptake of 18F-labeled 6-fluoro-6-deoxy-D-glucose by skeletal muscle is responsive to insulin stimulation.

Authors:  Chandra Spring-Robinson; Visvanathan Chandramouli; William C Schumann; Peter F Faulhaber; Yanming Wang; Chunying Wu; Faramarz Ismail-Beigi; Raymond F Muzic
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

Review 7.  Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Authors:  Roger K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

8.  Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites.

Authors:  Soong Lee; Seung-Cheol Son; Moon-Jong Han; Woo-Jin Kim; Soo-Hyun Kim; Hye-Ran Kim; Woo-Kyu Jeon; Ki-Hong Park; Myung-Geun Shin
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

9.  Relevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage Adjustments.

Authors:  Fiona V Bϋdingen; Daniel Gonzalez; Amelia N Tucker; Hartmut Derendorf
Journal:  Ther Adv Infect Dis       Date:  2014-02-01

10.  Impaired glucose and nutrient absorption in critical illness: is gastric emptying only a piece of the puzzle?

Authors:  Alain Dive
Journal:  Crit Care       Date:  2009-10-01       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.